METHOD FOR PREDICTING PNEUMONIA COMPLICATIONS OCCURRENCE Russian patent published in 2006 - IPC A61B10/00 

FIELD: medicine.

SUBSTANCE: method involves asking questions, evaluating five anamnesis parameters in 5-level scale with following calculation of pneumonia complications occurrence probability from equation of POP = 0.27+0.06xX1+0.05xX2+0.019xX3+0.021xX4+0.02xX5, where POP is the pneumonia complications occurrence probability; 0.27 is the free term; X1 is the time from disease manifestation to asking for medical care in points: 1 point - asking for medical care during the first hours of disease; 2 points - during the first 8 h; 3 points - during the first 8-12 h; 4 points - during the first 12-24 h; 5 points - longer than 1 day after the disease occurrence; X2 is the smoking time in points: 1 point - no smoking takes place; 2 points - smoking during 3 years; 3 points - 4-8 years; 4 points - 9-12 years; 5 points - longer than 12 years;. X3 is the time spent in hospital and acute respiratory virus infections in points: 1 point - no hospital in anamnesis; 2 points - hospitalization not related to bronchopulmonary diseases; 3 points - acute respiratory virus infections frequency is greater than 4 times a year; 4 points - frequently occurred bronchopulmonary diseases; 5 points - pneumonia or bronchitis occurred during the last year; X4 is the available chronic foci of respiratory virus infection in upper air passages, oral cavity, herpetic infection in points: 1 point - no chronic foci available; 2 points - chronic diseases of respiratory virus infection in upper air passages, oral cavity, herpetic infection w remission period longer than 1 year; 3 points - remission period is 6 months long; 4 points - exacerbation during the last 3 months available; 5 points - exacerbation available in current time; X5 is the concomitant diseases in points: 1 point - no concomitant diseases available; 2 points - concomitant bile duct dyskinesia, chronic gastritis, duodenitis, dysmetabolic nephropathy, urolithiasis; 3 points - chronic cholecystitis, pyelonephritis, prostatitis, adnexitis, cardiac ischemia disease, essential hypertension, helminthiasis; 4 points - chronic hepatitis, glomerulonephritis, myocardial dystrophy, lymphoadenopathy, tuberculosis infection; 5 points - mycotic lesions on skin and mucous membrane, acute respiratory virus infections, chronic concomitant diseases exacerbation at examination period. The POP value being <0.97 low risk is predicted; from 0.98 to 1.31 moderate risk degree; POP>1.32 - high risk of complications development.

EFFECT: high accuracy of diagnosis.

2 tbl